Im. Nobauerhuhmann et al., FACTOR-X FRANKFURT-I - MOLECULAR AND FUNCTIONAL-CHARACTERIZATION OF AHEREDITARY FACTOR-X DEFICIENCY (GLA(+25) TO LYS), Blood coagulation & fibrinolysis, 9(2), 1998, pp. 143-152
A family with hereditary factor X deficiency is presented. One member,
a 25-year-old man, showed a mild bleeding tendency. His factor X acti
vity (extrinsic: 56%; intrinsic: 55%; Russell's viper venom: 57%) and
his level of circulating factor X antigen (55% of normal) were markedl
y reduced. Analysis of his factor X gene revealed a single point mutat
ion within exon II resulting in the substitution of +25 Gla (GAA) by L
ys (AAA). The mutation was determined by gene analysis to be heterozyg
ous in this patient, his mother and one of his brothers. Clotting assa
ys of factor X purified from the plasma of the index patient revealed
an activity of 89% of normal upon activation with Russell's viper veno
m, 77% of normal in the intrinsic and 81% of normal in the extrinsic c
oagulation pathway. The mutation responsible for the substitution of L
ys for Gla(+25) 25 was introduced into an expression plasmid containin
g a wild type factor X cDNA and expressed in a mammalian cell line. Fa
ctor X antigen levels in the cell lysates and in the supernatant were
identical in the mutant and wild type constructs. The specific activit
y of the factor X expressed from the mutant construct was 3% compared
with the wild type construct. These data demonstrate that the substitu
tion of Lys for Gla(+25) 25 results not only in a reduced level of fac
tor X in the affected family members, but also in a substantial loss o
f specific factor X activity. (C) 1998 Lippincott-Raven Publishers.